These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32362867)

  • 41. Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease.
    Shah TM; Gupta SM; Chatterjee P; Campbell M; Martins RN
    Mol Psychiatry; 2017 Mar; 22(3):353-363. PubMed ID: 28093567
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subthreshold Amyloid Predicts Tau Deposition in Aging.
    Leal SL; Lockhart SN; Maass A; Bell RK; Jagust WJ
    J Neurosci; 2018 May; 38(19):4482-4489. PubMed ID: 29686045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses.
    Willén K; Sroka A; Takahashi RH; Gouras GK
    J Alzheimers Dis; 2017; 60(2):511-524. PubMed ID: 28869466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current drug targets for modulating Alzheimer's amyloid precursor protein: role of specific micro-RNA species.
    Long JM; Lahiri DK
    Curr Med Chem; 2011; 18(22):3314-21. PubMed ID: 21728971
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autophagic dysfunction in Alzheimer's disease: Cellular and molecular mechanistic approaches to halt Alzheimer's pathogenesis.
    Uddin MS; Mamun AA; Labu ZK; Hidalgo-Lanussa O; Barreto GE; Ashraf GM
    J Cell Physiol; 2019 Jun; 234(6):8094-8112. PubMed ID: 30362531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: tangle formation, amyloid-β, and microglia in Alzheimer's disease.
    Takata K; Kitamura Y
    J Pharmacol Sci; 2012; 118(3):331-7. PubMed ID: 22382659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cypermethrin Stimulates GSK3β-Dependent Aβ and p-tau Proteins and Cognitive Loss in Young Rats: Reduced HB-EGF Signaling and Downstream Neuroinflammation as Critical Regulators.
    Maurya SK; Mishra J; Abbas S; Bandyopadhyay S
    Mol Neurobiol; 2016 Mar; 53(2):968-982. PubMed ID: 25575682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA Dysregulation in Alzheimer's Disease.
    Putteeraj M; Fairuz YM; Teoh SL
    CNS Neurol Disord Drug Targets; 2017; 16(9):1000-1009. PubMed ID: 28782488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
    Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
    Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physical Activity Alleviates Cognitive Dysfunction of Alzheimer's Disease through Regulating the mTOR Signaling Pathway.
    Kou X; Chen D; Chen N
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease.
    Jazvinšćak Jembrek M; Slade N; Hof PR; Šimić G
    Prog Neurobiol; 2018 Sep; 168():104-127. PubMed ID: 29733887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TOM1 Regulates Neuronal Accumulation of Amyloid-β Oligomers by FcγRIIb2 Variant in Alzheimer's Disease.
    Gwon Y; Kam TI; Kim SH; Song S; Park H; Lim B; Lee H; Lee W; Jo DG; Jung YK
    J Neurosci; 2018 Oct; 38(42):9001-9018. PubMed ID: 30185465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
    Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus.
    Zhang ZX; Zhao RP; Wang DS; Li YB
    Neurochem Res; 2016 Nov; 41(11):3074-3082. PubMed ID: 27518086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Comprehensive Review of Membrane Transporters and MicroRNA Regulation in Alzheimer's Disease.
    Mishra S; Stany B; Das A; Kanagavel D; Vijayan M
    Mol Neurobiol; 2024 Nov; 61(11):8739-8758. PubMed ID: 38558361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological mTOR inhibitors in ameliorating Alzheimer's disease: current review and perspectives.
    Xie PL; Zheng MY; Han R; Chen WX; Mao JH
    Front Pharmacol; 2024; 15():1366061. PubMed ID: 38873415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
    Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
    Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sleep in Alzheimer's Disease - Beyond Amyloid.
    Holth J; Patel T; Holtzman DM
    Neurobiol Sleep Circadian Rhythms; 2017 Jan; 2():4-14. PubMed ID: 28217760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease.
    Minter MR; Taylor JM; Crack PJ
    J Neurochem; 2016 Feb; 136(3):457-74. PubMed ID: 26509334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.